A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonatesMitchell S. Cairo, Avroy A. Fanaroff, Bhagya L. Puppala et al.|The Journal of Pediatrics|1999Cited by 74
A DOUBLE BLINDED, RANDOMIZED, PLACEBO (P) CONTROLLED PILOT STUDY OF RhGM-CSF(GM) IN LOW BIRTH WEIGHT NEONATES (LBWN). PRELIMINARY RESULTS DEMONSTRATE A SIGNIFICANT REDUCTION IN NOSOCOMIAL INFECTIONS WITH RhuGM-CSMitchell S. Cairo, Jan M. Agosti, Tulika Seth et al.|Pediatric Research|1996Cited by 9